Oroxylin A inhibits glycolysis-dependent proliferation of human breast cancer via promoting SIRT3-mediated SOD2 transcription and HIF1α destabilization

Linzhi Wei(China Pharmaceutical University), Na Lu(Jinan University)
Cell Death and Disease
April 9, 2015
10.1038/cddis.2015.86
Cited by 87

Related Papers

Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma
|Cell Death and Disease|2013|137
Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer
|Journal of Experimental & Clinical Cancer Research|2018|93
Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway
|Oncotarget|2016|55
Wogonoside inhibits invasion and migration through suppressing TRAF2/4 expression in breast cancer
|Journal of Experimental & Clinical Cancer Research|2017|55
Lactate promotes PGE2 synthesis and gluconeogenesis in monocytes to benefit the growth of inflammation-associated colorectal tumor
|Oncotarget|2015|41